Shire in deal to develop a new way to administer hemophilia drug


REUTERS: Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A. The company, Rani Therapeutics, has developed a technology that will help oral delivery of peptides, proteins and therapeutic antibodies which to date could be delivered only through injections. Once delivered through Rani Pill - the oral delivery technology - the drug stays in the body until it enters the small intestine and transfers the medicine into the intestinal wall, the companies said.



from Biotech News